EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and …
GC Drosos, D Vedder, E Houben, L Boekel… - Annals of the …, 2022 - ard.bmj.com
Objective To develop recommendations for cardiovascular risk (CVR) management in gout,
vasculitis, systemic sclerosis (SSc), myositis, mixed connective tissue disease (MCTD) …
vasculitis, systemic sclerosis (SSc), myositis, mixed connective tissue disease (MCTD) …
[PDF][PDF] One year in review 2021: systemic vasculitis
F Ferro, L Quartuccio, S Monti, P Delvino… - Clin Exp …, 2021 - clinexprheumatol.org
Large-and small-vessel vasculitis are complex potentially life-threatening systemic
autoimmune diseases that have recently been subjected to considerable immunologic and …
autoimmune diseases that have recently been subjected to considerable immunologic and …
[HTML][HTML] EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
B Hellmich, B Sanchez-Alamo, JH Schirmer… - Annals of the …, 2024 - ard.bmj.com
Background Since the publication of the EULAR recommendations for the management of
antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several …
antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several …
Cardiovascular risk in vasculitis
The present review summarizes the burden, risk factors, biomarkers of and therapeutic
consideration for cardiovascular disease in systemic vasculitis. Ischemic heart disease (IHD) …
consideration for cardiovascular disease in systemic vasculitis. Ischemic heart disease (IHD) …
Increasing incidence and improved survival in ANCA-associated vasculitis—a Danish nationwide study
KE Nelveg-Kristensen, W Szpirt… - Nephrology Dialysis …, 2022 - academic.oup.com
Background Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)
carries a high risk of morbidity and mortality, with outcomes modified by treatment and an …
carries a high risk of morbidity and mortality, with outcomes modified by treatment and an …
At the heart of eosinophilic granulomatosis with polyangiitis: into cardiac and vascular involvement
Abstract Purpose of Review To provide an overview of existing literature on pathogenetic
and clinical aspects of cardiac and vascular involvement in eosinophilic granulomatosis with …
and clinical aspects of cardiac and vascular involvement in eosinophilic granulomatosis with …
High risk of stroke in ANCA-associated vasculitis—a population-based study
D Tabakovic, R Smith, D Jayne, AJ Mohammad - Rheumatology, 2023 - academic.oup.com
Objective To determine the incidence rate, predictors and outcome of stroke in a population-
based cohort of individuals with ANCA-associated vasculitis (AAV). Methods The study …
based cohort of individuals with ANCA-associated vasculitis (AAV). Methods The study …
Traditional and Disease-Specific Risk Factors for Cardiovascular Events in ANCA-Associated Vasculitis: A Multinational Retrospective Study
S Moiseev, N Bulanov, M Crnogorac… - The Journal of …, 2023 - jrheum.org
Objective To investigate the occurrence of cardiovascular events (CVEs) in a large cohort of
patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) across …
patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) across …
Predictors of cardiovascular events in patients with primary systemic vasculitis: a 5 years prospective observational study
A Borowiec, I Kowalik, T Chwyczko, J Jankowski… - European Journal of …, 2021 - Elsevier
Introduction: Granulomatosis with polyangiitis (GPA) is one of antineutrophil cytoplasmic
autoantibody (ANCA)–associated systemic vasculitis and is characterised by inflammation of …
autoantibody (ANCA)–associated systemic vasculitis and is characterised by inflammation of …
[HTML][HTML] New index using triglyceride glucose-body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
PG Park, JY Pyo, SS Ahn, JJ Song, YB Park… - Frontiers in …, 2023 - frontiersin.org
Background This study aimed to investigate whether triglyceride glucose-body mass index
(TyG-BMI) and a new index using TyG-BMI (NITGB) could predict all-cause mortality in non …
(TyG-BMI) and a new index using TyG-BMI (NITGB) could predict all-cause mortality in non …